| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7ddc4774cf5f8a0bda44a780d73c53d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
| filingDate |
2010-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7997126de7f7e531e4bb5a8f94f1d3a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36bc8402f4208cff5751874483155d0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_102f323829ea35e610998ca58d10f686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c783326d5c70d92f4bf8b351cd35f8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33bd443e8c010b9dd569477dc23fc075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17a13e8d138e16c7d0b3da6595f7e375 |
| publicationDate |
2012-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120036168-A |
| titleOfInvention |
Pharmaceutical formulations excellent in light stability comprising pitavastatins and colorants having a maximum absorption wavelength above 500 nm and below 600 nm |
| abstract |
The present invention relates to a pharmaceutical preparation containing pitavastatin with improved light stability, a colorant having a maximum absorption wavelength of less than 500 nm and less than 600 nm, and an additional light-shielding agent, wherein the pharmaceutical preparation is excellent in light stability and prevents exposure to light. By effectively inhibiting the degradation caused by, it can be utilized as a safe and effective therapeutic agent for hyperlipidemia and hypercholesterolemia. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104095850-A |
| priorityDate |
2010-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |